All clinical conditions

Clinical condition

Body Dysmorphic Disorder (BDD)

DSM-5 300.7 / ICD-11 6B21

Distressing preoccupation with a perceived flaw in appearance — an OCD-spectrum condition that is serious, common, and treatable.

Common ways people search for this

“body dysmorphic disorder treatment”“BDD obsessed with my appearance”“is BDD treatable”“ketamine for body dysmorphia”“I can't stop thinking about how I look”
The short version
  • ●BDD is a preoccupation with one or more perceived defects in physical appearance that others don't see or see as minor — driving significant distress and repetitive behaviors (mirror-checking, grooming, reassurance-seeking, comparing).
  • ●It is an obsessive-compulsive-spectrum disorder, related to OCD — not vanity — and it carries high rates of depression and one of the higher suicide risks in psychiatry.
  • ●First-line treatment is high-dose SSRIs and CBT tailored to BDD (with exposure and response prevention); cosmetic and surgical procedures do not help and often worsen it.
  • ●Insight is often poor, and many people suffer for years before diagnosis because the focus stays on the appearance concern rather than the underlying disorder.
  • ●Ketamine is not a treatment for BDD; like OCD, the BDD-specific evidence is essentially absent.
  • ●Ketamine's only role is for a co-occurring treatment-resistant depression, which is common and dangerous in BDD given the elevated suicide risk.

Clinical definition

Body dysmorphic disorder is defined by preoccupation with one or more perceived defects or flaws in physical appearance that are not observable or appear slight to others, accompanied by repetitive behaviors (mirror-checking, excessive grooming, skin-picking, reassurance-seeking) or mental acts (comparing one's appearance with others) performed in response. The preoccupation causes clinically significant distress or impairment and is not better explained by an eating disorder. Common areas of concern include the skin, hair, nose, and other facial features, though any body part can be involved; a muscle-focused variant (muscle dysmorphia) occurs mainly in men. DSM-5 classifies BDD within the Obsessive-Compulsive and Related Disorders, reflecting shared phenomenology and circuitry with OCD. Insight is frequently poor or absent (some patients hold near-delusional conviction), which contributes to under-diagnosis and to patients pursuing dermatologic or surgical "fixes." BDD carries high comorbidity with depression and social anxiety and notably high rates of suicidal ideation and attempts.

How it differs from related conditions

vs. OCD

Shares the obsession-compulsion structure and circuitry; BDD obsessions are specifically about appearance, and insight is more often poor than in OCD.

vs. Eating disorders

Both involve body-image disturbance, but eating disorders center on weight/shape and eating behavior; BDD focuses on specific appearance features and is diagnosed when not better explained by an eating disorder.

vs. Social anxiety disorder

BDD patients avoid social situations because of perceived appearance flaws specifically, rather than a general fear of judgment; the two often co-occur.

vs. Major depressive disorder

An extremely common comorbidity that must be screened and treated, especially given BDD's elevated suicide risk.

First-line treatments

High-dose SSRIs

First-line pharmacotherapy; like OCD, BDD often needs higher doses and longer trials than depression, and SSRIs reduce both the preoccupation and associated depression.

CBT tailored to BDD (with ERP)

The first-line psychotherapy — exposure to avoided situations, response prevention for checking and reassurance, and cognitive work on appearance beliefs.

Avoiding cosmetic/surgical procedures

Dermatologic and surgical interventions do not resolve BDD and frequently worsen it or shift the focus; steering patients away is part of care.

Treating comorbid depression and suicidality

Given high risk, active assessment and treatment of depression and suicide risk are essential.

When standard treatments fail

When high-dose SSRIs and BDD-focused CBT do not adequately help, the steps are to confirm adequate dose and duration (under-treatment is common), switch SSRI or add clomipramine, consider antipsychotic augmentation (particularly with poor or delusional insight), and ensure CBT was genuinely BDD-tailored with exposure and response prevention. Because suicide risk is high, vigilance for depression and suicidality is continuous. As in OCD, ketamine and other glutamatergic approaches are not established BDD treatments; their role is limited to a co-occurring treatment-resistant depression.

Where ketamine fits

Ketamine is not a treatment for body dysmorphic disorder, and — as with OCD, its sister OCD-spectrum disorder — there is essentially no BDD-specific evidence for it. The first-line treatments are high-dose SSRIs and BDD-tailored CBT with exposure and response prevention. Ketamine's only legitimate role is the treatment-resistant depression that so frequently accompanies BDD, which matters because BDD carries one of the higher suicide risks in psychiatry; ketamine's rapid antidepressant and anti-suicidal effects can be relevant for that comorbid depression. It does not treat the appearance preoccupation itself, and patients should understand that distinction. Tovani screens for the BDD/depression overlap rather than offering ketamine as a BDD remedy.

Where this fits with Tovani

Tovani treats the treatment-resistant depression that commonly co-occurs with BDD — not BDD itself, which calls for high-dose SSRIs and BDD-specific CBT. Given BDD's elevated suicide risk, eligibility screening pays particular attention to depression and suicidality, and patients are encouraged to engage BDD-focused therapy. Patients seeking ketamine to address appearance preoccupation are redirected to evidence-based BDD care; where a treatment-resistant depression coexists, ketamine for the depression is appropriate.
Check eligibilityFind treatment optionsThe science behind ketamine

Frequently asked

Is BDD just vanity?

No. BDD is a serious obsessive-compulsive-spectrum disorder, not vanity or self-absorption. The preoccupation is distressing and unwanted, drives compulsive behaviors, impairs life, and carries a high suicide risk. It deserves the same seriousness as any psychiatric condition — and it's treatable.

Will cosmetic surgery fix it?

No — and this is important. Cosmetic and dermatologic procedures don't resolve BDD and often worsen it or shift the focus to a new feature. Steering away from procedures and toward SSRIs and BDD-focused CBT is part of effective treatment.

What actually treats BDD?

High-dose SSRIs (often higher and longer than for depression) and CBT specifically tailored to BDD with exposure and response prevention. Comorbid depression and suicide risk are treated alongside. Most people improve meaningfully with adequate treatment.

Can ketamine help BDD?

Not the BDD itself — there is essentially no evidence ketamine treats the appearance preoccupation. Its only role is a co-occurring treatment-resistant depression, which is common and dangerous in BDD given the elevated suicide risk. Tovani screens for that overlap.

References

  1. Stein DJ et al. 2019, Nature Reviews Disease Primers — Review of obsessive-compulsive and related disorders, the spectrum to which BDD belongs, including treatment principles. (PMID 31371720)
  2. Mataix-Cols D et al. 2025, Journal of Psychiatric Research — Empirically informed symptom-severity work in body dysmorphic disorder, supporting measurement-based BDD care. (PMID 40578059)
  3. Sanacora G et al. 2017, JAMA Psychiatry — APA consensus on ketamine, relevant to the treatment-resistant depression common in BDD. (PMID 28249076)

Last reviewed by Dr. Ben Soffer, DO on May 31, 2026. This page is educational and not a substitute for clinical evaluation. A physician determines whether ketamine therapy is appropriate for your specific situation.